This novel microorganism was identified through research efforts prompted by the observation that affected patients had similar pneumonia symptoms and Jiatong et al. [4] demonstrated that as with SARS-CoV, SARS-CoV-2 also enters the cell by binding to the angiotensin converting enzyme 2 (ACE-2) cell receptor [5]. This evidence concerns the gene ACE2 and pneumonia.